A. Howell

Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8+ T cells and exhibit a distinct CD95hi B cell phenotype

F. Wong, K. Ladell, C. Dayan, 2020, Diabetologia.

Detecting autoreactive B cells in the peripheral blood of people with type 1 diabetes using ELISpot.

F. Wong, C. Dayan, G. Dunseath, 2019, Journal of immunological methods.

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes

F. Wong, Martina A. McAteer, J. Ludvigsson, 2022, Immunotherapy advances.

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes

C. Beam, F. Wong, R. Hills, 2017, Science Translational Medicine.

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes

C. Beam, F. Wong, R. Hills, 2017, Science Translational Medicine.